Skip to main content
. Author manuscript; available in PMC: 2015 May 19.
Published in final edited form as: Neurocrit Care. 2014 Jun;20(3):382–389. doi: 10.1007/s12028-014-9966-y

Table 2. Univariate Associations 24 Hours Prior to Complication Onset.

Controls
(N=125)
Infection
(N=77)
DCI
(N=34)
Statistic a P
Demographics
 Age ≥ 53b 74 (59%) 51 (66%) 17 (50%) 2.66 0.26
 Women 82 (66%) 51 (66%) 26 (76%) 1.41 0.49
 Non-white Ethnicity 71 (57%) 52 (68%) 20 (59%) 2.17 0.34
Clinical Factors
 Loss of consciousness at ictus 69 (55%) 36 (47%) 15 (45%) 2.22 0.33
 Hunt-Hess Grade ≥ 4 60 (48%) 32 (42%) 13 (38%) 1.56 0.46
 Glasgow Coma Scale ≤ 8 58 (47%) 29 (38%) 9 (26%) 5.25 0.07
 APACHE II score - Physiological 8 (6,13) 7 (5,11) 7 (5,9) 3.77 0.02
 Fever > 38° C 40 (32%) 52 (68%) 21 (62%) 26.14 <0.001
 External Ventricular Drain 56 (45%) 48 (62%) 20 (59%) 6.51 0.04
Aneurysm Characteristics
 Size ≥ 10 mm 16 (13%) 9 (12%) 4 (12%) 0.08 0.96
 Clipping Procedure 37 (30%) 45 (58%) 27 (79%) 29.91 <0.001
Admission Echocardiogram
 Ejection Fraction ≤ 40% 15 (12%) 16 (21%) 7 (21%) 3.21 0.20
 Any Wall Motion Abnormalities 17 (14%) 10 (13%) 5 (15%) 0.06 0.97
Admission CT
 Admission Cerebral Edema 67 (54%) 48 (62%) 21 (62%) 1.59 0.45
 Hijdra SAH Sum Score ≥15 79 (63%) 44 (57%) 25 (76%) 3.84 0.15
 IVH present 81 (65%) 59 (79%) 21 (64%) 4.08 0.13
 ICH present 22 (18%) 14 (19%) 10 (30%) 2.57 0.28
 Bicaudate Index ≥16 48 (38%) 44 (62%) 16 (50%) 6.35 0.04
TCD Flow Velocity
 Maximum Velocity > 120 cm/sec 11 (9%) 13 (17%) 18 (53%) 35.38 <0.001
White Blood Cell Count
 <4000/mm3 or >12000/mm3 13 (10%) 39 (51%) 18 (53%) 46.83 <0.001
Medications
 Beta Blockers 2 (2%) 5 (6%) 0 (0%) 5.18 0.08
 Vasopressor support 15 (12%) 17 (22%) 11 (32%) 8.57 0.01
 Propofol 12 (10%) 16 (21%) 4 (12%) 5.19 0.08
 Analgesia and Sedation 12 (10%) 11 (14%) 5 (15%) 1.31 0.52

Values are N (%), median (25%, 75%);

a

Chi-square test for dichotomized variables, general linear model for continuous variables;

b

Dichotomized at median age